Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Monozyme India Ltd (522199)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 522199 NSE: Hospital & Healthcare Services | Small Cap | Monozyme India Share Price
BSE Share Price
Not Listed
Not Listed
Monozyme India Ltd (522199)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 522199 NSE: Hospital & Healthcare Services | Small Cap | Monozyme India Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹3 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
99.8
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-99.41%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
9.39%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹3.2 Cr.
Face Value
₹5
All Time Low / High
₹0.05 / 47.50
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'99 | Mar'00 | Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 13.2% | 11.8% | 12.9% | 11.3% | 13.5% | 19.2% | 11.4% | 13.3% | -9.8% | 3.8% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 3.9 | 4.4 | 4.8 | 5.8 | 9.8 | 12.6 | 9.4 | 10.6 | 5.1 | 0 | 0 |
| Sales YoY Gr. | - | 12.9% | 9.1% | 20.7% | 69% | 28.7% | -25% | 12% | -52% | -99.4% | - |
| Adj EPS ⓘ | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.6 | 0.2 | 0.5 | -2 | -0.8 | -0.3 |
| YoY Gr. | - | 12.5% | 88.9% | 11.8% | 31.6% | 132% | -65.5% | 155% | -498% | NA | - |
| BVPS (₹) ⓘ | 3.2 | 3 | 3.1 | 3.2 | 3.3 | 3.9 | 4.1 | 4.6 | 2.5 | 2.3 | 2.3 |
| Adj Net Profit ⓘ | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.1 | 0.3 | -1.3 | -0.5 | -0 |
| Cash Flow from Ops. ⓘ | 0.2 | -0.4 | 0.2 | 0.3 | -0 | -0.4 | -0.2 | -1.4 | -0.2 | 1.2 | - |
| Debt/CF from Ops. ⓘ | 11.3 | -5.1 | 9.6 | 7.1 | -58.1 | -7 | -17.1 | -4 | -22.4 | 2.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -41.8% | -68.6% | -85.3% | -99.4% | ||||
| Adj EPS ⓘ | -228.8% | -225.6% | -257.4% | NA | ||||
| BVPSⓘ | -3.8% | -7% | -18% | -11% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'99 | Mar'00 | Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 1.4 | 1.5 | 2.9 | 3.2 | 4 | 11.5 | 5.1 | 11.9 | -58 | -33.3 | -11.8 |
| Op. Profit Mgn % ⓘ | 14 | 10.8 | 11.9 | 8.4 | 5.9 | 7.4 | 6.7 | 8.7 | -12.8 | -4203.4 | -241.3 |
| Net Profit Mgn % ⓘ | 1.4 | 1.3 | 2.3 | 2.1 | 1.6 | 2.9 | 1.3 | 3.1 | -25.6 | -1447 | -574.2 |
| Debt to Equity ⓘ | 0.9 | 1.1 | 1 | 0.9 | 1 | 1.1 | 1 | 1.9 | 3.1 | 1.9 | - |
| Working Cap Days ⓘ | 400 | 375 | 319 | 249 | 191 | 198 | 269 | 254 | 522 | 55,566 | 0 |
| Cash Conv. Cycle ⓘ | 17 | 31 | 85 | 87 | 53 | 49 | 64 | 110 | 354 | 52,286 | 0 |
Valuation of Monozyme India - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Monozyme India Ltd FAQs
The current trading price of Monozyme India on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Monozyme India stood at ₹2.82 Cr
The latest P/E ratio of Monozyme India as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Monozyme India as of 31-Dec-1969 is 1.90.
The 52-week high of Monozyme India is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Monozyme India is ₹0.03 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Monozyme India Ltd
Monozyme India was incorporated on July 7, 1989, as a private company for the purpose of manufacturing diagnostic kits. Subsequently, the company was converted into a public company vide special resolution passed in the annual general meeting of the company held on September 30, 1991. The company obtained fresh certificate of incorporation consequent on change of name from the Registrar of Companies, Andhra Pradesh on October 31, 1991. Monozyme India is promoted by A R Vishwanath & Associates. The company commenced commercial operations on May 15, 1991.
The manufacturing plant of the company is located at Secunderabad in Andhra Pradesh. Constant in-house research and development is undertaken and new technology developed thereon is absorbed.
The registered office is at Flat 402, S.S. Residency, Plot No. 3, Center Point, Brig Syed Road, Secunderabad-500009, Andhra Pradesh.
Business area of the company
Monozyme India is engaged in the business of diagnostic and clinical chemistry kits and enzymes.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
